Four months after it launched a clinical trial accelerator, Fresenius‘s (NYSE:FMS) renal research arm Frenova disclosed the initial participants. Fourteen research centers around the U.S. will take part in the F1RST Up accelerator (Frenova Rapid Start Up). Frenova general manager said in prepared remarks that the participants include “some of the most productive clinical research […]
Frenova Renal Research
Fresenius’ Frenova launches clinical trial accelerator
Dialysis giant Fresenius‘s (NYSE:FMS) renal research branch Frenova said today it launched a renal research accelerator, titled F1RST Up, through an alliance of physician investigators in the nephrology research field. The accelerator aims to boost study startup through the elimination of administrative and contracting burdens that plague clinical trials, and are often responsible for delays, the […]